352 related articles for article (PubMed ID: 32112863)
1. Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects.
Noleto Dias C; Nunes TAL; Sousa JMS; Costa LH; Rodrigues RRL; Araújo AJ; Marinho Filho JDB; da Silva MV; Oliveira MR; Carvalho FAA; Rodrigues KADF
Chem Biol Interact; 2020 Apr; 320():109026. PubMed ID: 32112863
[TBL] [Abstract][Full Text] [Related]
2. Solidagenone acts on promastigotes of L. amazonensis by inducing apoptosis-like processes on intracellular amastigotes by IL-12p70/ROS/NO pathway activation.
Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Contato VM; Silva TF; de Matos RLN; Detoni MB; Rodrigues ACJ; Carloto AC; Lazarin DB; Arakawa NS; Costa IN; Conchon-Costa I; Miranda-Sapla MM; Wowk PF; Pavanelli WR
Phytomedicine; 2021 May; 85():153536. PubMed ID: 33765552
[TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of cordiaquinone E towards Leishmania (Leishmania) amazonensis.
Rodrigues RRL; Nunes TAL; de Araújo AR; Marinho Filho JDB; da Silva MV; Carvalho FAA; Pessoa ODL; Freitas HPS; Rodrigues KADF; Araújo AJ
Int Immunopharmacol; 2021 Jan; 90():107124. PubMed ID: 33168414
[TBL] [Abstract][Full Text] [Related]
4. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative Activity and Ultrastructural Changes in Promastigote and Amastigote forms of Leishmania amazonensis Caused by Limonene-Acylthiosemicarbazide Hybrids.
Graça Contato A; Kaplum V; Botura Scariot D; Pelegrin Garcia F; Falzirolli H; Vandresen F; Ueda-Nakamura T; de Oliveira Silva S; Conceição da Silva C; Vataru Nakamura C
Chem Biodivers; 2023 Jul; 20(7):e202300523. PubMed ID: 37263974
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial activity of verbascoside: Selective arginase inhibition of intracellular amastigotes of Leishmania (Leishmania) amazonensis with resistance induced by LPS plus IFN-γ.
Maquiaveli CDC; Rochetti AL; Fukumasu H; Vieira PC; da Silva ER
Biochem Pharmacol; 2017 Mar; 127():28-33. PubMed ID: 28017773
[TBL] [Abstract][Full Text] [Related]
7. Curzerene antileishmania activity: Effects on Leishmania amazonensis and possible action mechanisms.
Nunes TAL; Santos MM; de Oliveira MS; de Sousa JMS; Rodrigues RRL; Sousa PSA; de Araújo AR; Pereira ACTDC; Ferreira GP; Rocha JA; Rodrigues Junior V; da Silva MV; Rodrigues KADF
Int Immunopharmacol; 2021 Nov; 100():108130. PubMed ID: 34500286
[TBL] [Abstract][Full Text] [Related]
8. Grandiflorenic acid promotes death of promastigotes via apoptosis-like mechanism and affects amastigotes by increasing total iron bound capacity.
Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; de Carvalho PGC; Cardoso ILA; Simão ANC; Arakawa NS; Costa IN; Conchon-Costa I; Pavanelli WR
Phytomedicine; 2018 Jul; 46():11-20. PubMed ID: 30097110
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
Gonzalez-Fajardo L; Fernández OL; McMahon-Pratt D; Saravia NG
PLoS Negl Trop Dis; 2015 May; 9(5):e0003820. PubMed ID: 26024228
[TBL] [Abstract][Full Text] [Related]
10. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
[TBL] [Abstract][Full Text] [Related]
11. Eugenia piauhiensis Vellaff. essential oil and γ-elemene its major constituent exhibit antileishmanial activity, promoting cell membrane damage and in vitro immunomodulation.
Nunes TAL; Costa LH; De Sousa JMS; De Souza VMR; Rodrigues RRL; Val MDCA; Pereira ACTDC; Ferreira GP; Da Silva MV; Da Costa JMAR; Véras LMC; Diniz RC; Rodrigues KADF
Chem Biol Interact; 2021 Apr; 339():109429. PubMed ID: 33713644
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
Valentim-Silva JR; Macedo SRA; de Barros NB; Dos Santos Ferreira A; da Silva JHM; de Figueiredo Nicolete LD; Nicolete R
Int Immunopharmacol; 2020 Aug; 85():106640. PubMed ID: 32470884
[TBL] [Abstract][Full Text] [Related]
13. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
[TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
16. Syzygium cumini (L.) Skeels essential oil and its major constituent α-pinene exhibit anti-Leishmania activity through immunomodulation in vitro.
Rodrigues KA; Amorim LV; Dias CN; Moraes DF; Carneiro SM; Carvalho FA
J Ethnopharmacol; 2015 Feb; 160():32-40. PubMed ID: 25460590
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2'-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment.
Oliveira LFG; Souza-Silva F; de Castro Côrtes LM; Cysne-Finkelstein L; de Souza Pereira MC; de Oliveira Junior FO; Pinho RT; Corte Real S; Bourguignon SC; Ferreira VF; Alves CR
Molecules; 2018 Apr; 23(4):. PubMed ID: 29642584
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and Antileishmanial Effects of the Monoterpene β-Ocimene.
Sousa JMS; Nunes TAL; Rodrigues RRL; Sousa JPA; Val MDCA; Coelho FADR; Santos ALSD; Maciel NB; Souza VMR; Machado YAA; Sousa PSA; Araújo AR; Rocha JA; Sousa DP; Silva MVD; Arcanjo DDR; Rodrigues KADF
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259336
[TBL] [Abstract][Full Text] [Related]
20. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
